• LAST PRICE
    7.3800
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-0.5391%)
  • Bid / Lots
    7.2200/ 1
  • Ask / Lots
    7.4200/ 2
  • Open / Previous Close
    7.4000 / 7.4200
  • Day Range
    Low 7.2400
    High 7.6400
  • 52 Week Range
    Low 5.0100
    High 12.7500
  • Volume
    397,960
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 7.42
TimeVolumeCMPS
09:32 ET108957.35
09:34 ET1007.415
09:36 ET2007.4
09:38 ET29627.59
09:39 ET1007.575
09:41 ET31757.625
09:43 ET9297.625
09:45 ET1007.605
09:48 ET8967.6
09:50 ET7507.5987
09:52 ET36657.56
09:54 ET22007.56
09:56 ET1007.54
09:57 ET102257.49
09:59 ET24497.45
10:01 ET1007.475
10:03 ET14727.49
10:06 ET1007.45
10:10 ET1007.4998
10:12 ET44617.4
10:14 ET19057.42
10:15 ET6627.375
10:17 ET2007.4138
10:19 ET75517.4
10:21 ET5007.4
10:24 ET11117.46
10:30 ET7177.415
10:32 ET39427.4
10:35 ET1007.38
10:37 ET1927.375
10:42 ET11257.38
10:44 ET4007.37
10:48 ET17427.34
10:50 ET9507.37
10:57 ET11237.36
11:00 ET36977.34
11:04 ET2007.34
11:06 ET1007.32
11:11 ET2407.31
11:13 ET1007.31
11:15 ET22177.357
11:18 ET11177.34
11:22 ET3717.34
11:24 ET2807.355
11:26 ET24947.375
11:29 ET1007.37
11:31 ET6007.3797
11:33 ET1007.376
11:36 ET1007.36
11:40 ET4977.34
11:44 ET5007.3413
11:47 ET10507.37
11:51 ET1007.35
11:58 ET6007.36
12:00 ET1007.36
12:02 ET1007.35
12:03 ET1347.369
12:05 ET2007.36
12:14 ET1007.34
12:16 ET5007.35
12:18 ET5007.341
12:21 ET2007.35
12:23 ET3007.35
12:25 ET8977.35
12:27 ET1007.345
12:36 ET6467.335
12:39 ET11977.36
12:43 ET2007.31
12:45 ET3507.3001
12:50 ET9467.32
12:52 ET1007.315
12:54 ET3507.32
12:57 ET4007.31
12:59 ET3007.31
01:01 ET4007.33
01:03 ET2007.34
01:06 ET1007.35
01:08 ET1507.335
01:10 ET7007.35
01:12 ET28807.35
01:15 ET2757.3301
01:17 ET11007.31
01:19 ET27047.315
01:21 ET4007.32
01:24 ET18007.31
01:26 ET8397.294
01:28 ET2007.31
01:30 ET20007.305
01:32 ET18007.295
01:33 ET1367.3074
01:35 ET5937.27
01:37 ET1007.275
01:39 ET4007.26
01:42 ET25607.25
01:44 ET95437.28
01:46 ET77507.26
01:48 ET16507.25
01:50 ET25817.28
01:51 ET2007.29
01:53 ET1007.26
01:57 ET10067.26
02:00 ET2807.25
02:02 ET52007.3
02:04 ET2007.3
02:08 ET8007.265
02:13 ET1247.2799
02:15 ET18707.27
02:18 ET28077.28
02:20 ET19587.275
02:22 ET2077.275
02:24 ET11127.28
02:26 ET4757.2719
02:27 ET37507.27
02:29 ET269947.36
02:31 ET24107.35
02:33 ET64607.335
02:36 ET4007.32
02:40 ET4007.28
02:42 ET2007.31
02:44 ET1007.29
02:45 ET4007.29
02:47 ET37767.32
02:49 ET5007.32
02:51 ET2007.32
02:54 ET17827.3
02:56 ET16007.32
03:02 ET1007.28
03:03 ET6007.28
03:05 ET29007.3
03:07 ET2007.28
03:09 ET3087.27
03:12 ET4007.27
03:16 ET15007.27
03:18 ET24007.305
03:21 ET1007.29
03:23 ET21007.3099
03:25 ET5647.307
03:27 ET4007.28
03:30 ET5007.28
03:32 ET3007.28
03:34 ET15417.295
03:36 ET6007.29
03:38 ET7187.29
03:39 ET9657.29
03:41 ET45327.29
03:43 ET15477.29
03:45 ET52327.29
03:48 ET5007.3
03:50 ET23727.29
03:52 ET38627.335
03:54 ET7727.335
03:56 ET93197.345
03:57 ET36097.37
03:59 ET782287.38
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCMPS
Compass Pathways PLC
504.7M
-3.1x
---
United StatesAVTE
Aerovate Therapeutics Inc
502.7M
-5.8x
---
United StatesLRMR
Larimar Therapeutics Inc
510.4M
-8.3x
---
United StatesKALV
Kalvista Pharmaceuticals Inc
492.3M
-3.7x
---
United StatesCABA
Cabaletta Bio Inc
491.9M
-5.9x
---
United StatesATXS
Astria Therapeutics Inc
520.0M
-4.1x
---
As of 2024-06-02

Company Information

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Contact Information

Headquarters
3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
Phone
---
Fax
---

Executives

Interim Independent Chairman of the Board
David Norton
Chief Executive Officer, Executive Director
Kabir Nath
Chief Financial Officer, Principal Accounting Officer
Teri Loxam
General Counsel, Chief Legal Officer
Matthew Owens
Chief Medical Officer
Guy Goodwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$504.7M
Revenue (TTM)
$0.00
Shares Outstanding
68.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.33
EPS
$-2.37
Book Value
$3.64
P/E Ratio
-3.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.